| # | Drug | Count |
|---|---|---|
| 0 | SUNITINIB MALATE | 196 |
| 1 | PAZOPANIB HYDROCHLORIDE | 90 |
| 2 | CABOZANTINIB | 57 |
| 3 | AXITINIB | 46 |
| 4 | OMEPRAZOLE MAGNESIUM | 40 |
| 5 | ASPIRIN | 38 |
| 6 | ASPIRIN 325 MG | 37 |
| 7 | ASPIRIN 81 MG | 37 |
| 8 | EVEROLIMUS | 35 |
| 9 | NIVOLUMAB | 31 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SUNITINIB MALATE | 196 | 0.0050 |
| 1 | PAZOPANIB HYDROCHLORIDE | 90 | 0.0033 |
| 2 | TEMSIROLIMUS | 15 | 0.0033 |
| 3 | AXITINIB | 46 | 0.0024 |
| 4 | MARC GLASSMAN | 5 | 0.0014 |
| 5 | DOCUSATE SODIUM AND SENNOSIDES | 6 | 0.0014 |
| 6 | ACARBOSE | 5 | 0.0013 |
| 7 | DOCUSATE SODIUM SENNOSIDES | 6 | 0.0012 |
| 8 | CABOZANTINIB | 57 | 0.0012 |
| 9 | DOCUSATE CALCIUM | 5 | 0.0011 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 5 | 0.0010 |
| 1 | Provitamin D2 Compound [EPC] | 30 | 0.0010 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 37 | 0.0004 |
| 3 | Kinase Inhibitor [EPC] | 105 | 0.0002 |
| 4 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 10 | 0.0002 |
| 5 | Integrin Receptor Antagonist [EPC] | 13 | 0.0001 |
| 6 | Thiazide-like Diuretic [EPC] | 6 | 0.0001 |
| 7 | Aluminum Complex [EPC] | 3 | 0.0001 |
| 8 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 4 | 0.0001 |
| 9 | Central alpha-2 Adrenergic Agonist [EPC] | 6 | 0.0001 |